Effect of cysteine mutations on direct electron transfer of horseradish peroxidase on gold.

Surface exposed cysteines were genetically engineered in the structure of recombinant horseradish peroxidase (rHRP). Recombinant forms of HRP with either a His-tag or a Strep-tag at the C-terminus were produced, which additionally had cysteines at positions 57, 189 or 309 (C-terminus) of the polypeptide chain. An E. coli expression system was exploited. The effect of these mutations on the direct electron transfer (ET) between Au and the enzyme was studied in the reaction of the bioelectrocatalytic reduction of H(2)O(2), at -50 mV versus Ag/AgCl, on rHRP-modified Au electrodes placed in a wall-jet flow-through electrochemical cell. Adsorptive immobilisation of rHRPs on pre-oxidised Au from the protein solution at pH 6.0 provided a high and stable current response to H(2)O(2) due to its bioelectrocatalytic reduction based on direct (mediatorless) ET between Au and the active site of the rHRPs. Comparative analysis of the direct ET rate constants, estimated from the amperometric data on direct and mediated ET in the presence of catechol at pH 7.4 and 6.0, gave evidence that the introduction of the His-tag or cysteine in the C-terminal area of the enzyme resulted in an increased efficiency of direct ET due to a favourable coupled electron and proton transfer pathway. Due to the high efficiency of direct ET, the sensitivity was independent on the addition of the mediator or change of pH indicating that the response to H(2)O(2) is determined solely by the mass transfer of the analyte to the active site of HRP. The sensitivities obtained for the Au electrodes modified with rHRPs (2.0+/-0.1 A M(-1) cm(-2)) and the low detection limit for H(2)O(2) (10 nM) paves the way to develop the P-chip (peroxidase chip)--a biosensors system of a microscopic size for a mediatorless detection of H(2)O(2) based on direct ET between Au and the recombinant forms of HRP.

Monoclonal antibody S60-4-14 reveals diagnostic potential in the identification of Pseudomonas aeruginosa in lung tissues of cystic fibrosis patients.

The lipopolysaccharide (LPS) of Pseudomonas aeruginosa has been identified to contain an inner-core structure expressing a Pseudomonas-specific epitope. This target structure is characterized by a highly phosphorylated and 7-O-carbamoyl-l-glycero-alpha-d-manno-heptopyranose (CmHep) and was found to be present in all human-pathogenic Pseudomonas species of the Palleroni (RNA)-classification I scheme. We raised and selected the monoclonal antibody S60-4-14 (mAb S60-4-14, subtype IgG1) from mice immunized with heat-killed Pseudomonas bacteria. The epitope of this mAb was found to reside in the inner-core structure of P. aeruginosa and, hence, successfully evaluated for the immunohistochemical detection of P. aeruginosa in formalin- or HOPE-fixed (Hepes-glutamic acid buffer-mediated organic solvent protection effect) and paraffin-embedded human lung tissue slices. Lung specimens, mainly from explanted lungs of cystic fibrosis (CF) patients, as well as P. aeruginosa isolates from patients suffering from CF and patients with extrapulmonar Pseudomonas infections were investigated by PCR, immunohistochemistry, and Western blot analysis with mAb S60-4-14. The results revealed an unequivocal coincidence of PCR and immunohistochemistry. Together with the Western blot results mAb S60-4-14 displays a potential diagnostic tool for the specific identification of P. aeruginosa in infected lungs of CF.